Jacobs BC - Search Results

1

Genetic polymorphisms of macrophage-mediators in Guillain-Barré syndrome.

Geleijns K, Emonts M, Laman JD, van Rijs W, van Doorn PA, Hermans PW, Jacobs BC. Geleijns K, et al. Among authors: jacobs bc. J Neuroimmunol. 2007 Oct;190(1-2):127-30. doi: 10.1016/j.jneuroim.2007.07.008. Epub 2007 Aug 30. J Neuroimmunol. 2007. PMID: 17761309

2

The Guillain-Barré syndrome: a true case of molecular mimicry.

Ang CW, Jacobs BC, Laman JD. Ang CW, et al. Among authors: jacobs bc. Trends Immunol. 2004 Feb;25(2):61-6. doi: 10.1016/j.it.2003.12.004. Trends Immunol. 2004. PMID: 15102364 Review.

3

The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.

Godschalk PC, Heikema AP, Gilbert M, Komagamine T, Ang CW, Glerum J, Brochu D, Li J, Yuki N, Jacobs BC, van Belkum A, Endtz HP. Godschalk PC, et al. Among authors: jacobs bc. J Clin Invest. 2004 Dec;114(11):1659-65. doi: 10.1172/JCI15707. J Clin Invest. 2004. PMID: 15578098 Free PMC article.

4

Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain-Barre syndrome.

Geleijns K, Laman JD, van Rijs W, Tio-Gillen AP, Hintzen RQ, van Doorn PA, Jacobs BC. Geleijns K, et al. Among authors: jacobs bc. J Neuroimmunol. 2005 Apr;161(1-2):183-9. doi: 10.1016/j.jneuroim.2004.12.001. J Neuroimmunol. 2005. PMID: 15748958

5

Severity of Guillain-Barré syndrome is associated with Fc gamma Receptor III polymorphisms.

van Sorge NM, van der Pol WL, Jansen MD, Geleijns KP, Kalmijn S, Hughes RA, Rees JH, Pritchard J, Vedeler CA, Myhr KM, Shaw C, van Schaik IN, Wokke JH, van Doorn PA, Jacobs BC, van de Winkel JG, van den Berg LH. van Sorge NM, et al. Among authors: jacobs bc. J Neuroimmunol. 2005 May;162(1-2):157-64. doi: 10.1016/j.jneuroim.2005.01.016. J Neuroimmunol. 2005. PMID: 15833371

6

Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA.

Kuijf ML, van Doorn PA, Tio-Gillen AP, Geleijns K, Ang CW, Hooijkaas H, Hop WC, Jacobs BC. Kuijf ML, et al. Among authors: jacobs bc. J Neurol Sci. 2005 Dec 15;239(1):37-44. doi: 10.1016/j.jns.2005.07.009. Epub 2005 Sep 8. J Neurol Sci. 2005. PMID: 16154154

7

Co-infection with two different Campylobacter jejuni strains in a patient with the Guillain-Barré syndrome.

Godschalk PC, Gilbert M, Jacobs BC, Kramers T, Tio-Gillen AP, Ang CW, Van den Braak N, Li J, Verbrugh HA, Van Belkum A, Endtz HP. Godschalk PC, et al. Among authors: jacobs bc. Microbes Infect. 2006 Jan;8(1):248-53. doi: 10.1016/j.micinf.2005.06.022. Epub 2005 Sep 13. Microbes Infect. 2006. PMID: 16213180 Free article.

8

Presence or absence of cytomegalovirus in cerebrospinal fluid from patients with Guillain-Barré syndrome?

Kuijf ML, Ang CW, van Doorn PA, Niesters HG, Jacobs BC. Kuijf ML, et al. Among authors: jacobs bc. J Infect Dis. 2006 May 15;193(10):1471-2; author reply 1472-3. doi: 10.1086/503440. J Infect Dis. 2006. PMID: 16619197 No abstract available.

9

Mannose-binding lectin contributes to the severity of Guillain-Barré syndrome.

Geleijns K, Roos A, Houwing-Duistermaat JJ, van Rijs W, Tio-Gillen AP, Laman JD, van Doorn PA, Jacobs BC. Geleijns K, et al. Among authors: jacobs bc. J Immunol. 2006 Sep 15;177(6):4211-7. doi: 10.4049/jimmunol.177.6.4211. J Immunol. 2006. PMID: 16951387

10

Predicting the course of Guillain-Barré syndrome.

van Doorn PA, Jacobs BC. van Doorn PA, et al. Among authors: jacobs bc. Lancet Neurol. 2006 Dec;5(12):991-3. doi: 10.1016/S1474-4422(06)70606-8. Lancet Neurol. 2006. PMID: 17110272 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

282 results

Search Page